Safety and Pharmacokinetics Study of ODM-201 in Castrate Resistant Prostate Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Klinika Onkologie A Radioterapie Lfuk A Fn
Hradec Králové, Czechia
- Fakultni Nemonicnice Olomouc
Olomouc, Czechia
- Oddeleni Radiacni A Klinicke Onkologie Nemocnice Znojmo
Znojmo, Czechia
- East-Tallinn Central Hospital
Talinn, Estonia
- Helsinki University Central Hospital
Helsinki, Finland
- Kuopio University Hospital
Kuopio, Finland
- Oulu University Hospital
Oulu, Finland
- Tampere University Hospital
Tampere, Finland
- Turku University Hospital
Turku, Finland
- Saint Louis Hospital
Paris, France
- Institut Gustave Roussy
Villejuif, France
- Queen Elizabeth Hospital
Birmingham, United Kingdom
- Velindre Cancer Centre
Cardiff, United Kingdom
- Christie Hospital
Manchester, United Kingdom
- Churchill Hospital
Oxford, United Kingdom
- the Urology Center of Colorado
Wheat Ridge, Colorado, United States
- Eastern Ct Hematology and Oncology Associates
Norwich, Connecticut, United States
- Urology Health Team Pllc
Ocala, Florida, United States
- Chesapeake Urology Research Associates
Baltimore, Maryland, United States
- Delaware Valley Urology, Llc
Voorhees Township, New Jersey, United States
- Brooklyn Urology Research Group
Brooklyn, New York, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Carolina Urologic Research Center
Myrtle Beach, South Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2011
- Primary completion
- 31 Jul 2013
- Completion
- 31 Jul 2013
- Last update posted
- 29 Mar 2017
- Registered enrollment
- 136
- Registry id
- NCT01317641
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.